Replimune Group, Inc.
REPL
$8.02
$0.040.50%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 4.04% | 69.71% | 124.30% | 55.87% | 30.86% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.96% | 43.42% | 58.10% | 35.62% | 16.96% |
| Operating Income | -8.96% | -43.42% | -58.10% | -35.62% | -16.96% |
| Income Before Tax | -8.33% | -56.63% | -61.22% | -34.63% | -29.85% |
| Income Tax Expenses | -154.09% | -- | -- | -64.62% | 21.56% |
| Earnings from Continuing Operations | -6.92% | -56.63% | -61.22% | -34.60% | -29.77% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -6.92% | -56.63% | -61.22% | -34.60% | -29.77% |
| EBIT | -8.96% | -43.42% | -58.10% | -35.62% | -16.96% |
| EBITDA | -9.38% | -44.79% | -59.15% | -36.66% | -14.03% |
| EPS Basic | 3.16% | -33.88% | -20.34% | 1.27% | -3.59% |
| Normalized Basic EPS | 1.89% | -33.91% | -20.35% | 1.26% | -3.64% |
| EPS Diluted | 3.16% | -33.88% | -20.34% | 1.27% | -3.59% |
| Normalized Diluted EPS | 1.89% | -33.91% | -20.35% | 1.26% | -3.64% |
| Average Basic Shares Outstanding | 10.41% | 16.99% | 33.97% | 36.34% | 25.29% |
| Average Diluted Shares Outstanding | 10.41% | 16.99% | 33.97% | 36.34% | 25.29% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |